Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1880 per EA under NDC 67877059305. Its NADAC has been published 73 times since May 14, 2025.
FDA first approved this application on Nov 25, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877059305
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA211143FDA Approved
11/25/2020
TE Code
AB
On Market Since
11/27/2020
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 73 times since May 14, 2025, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1880 per EA |
|---|---|
| All-time high | $0.2122 (May 14, 2025) |
| All-time low | $0.1588 (Sep 17, 2025) |
| 52-week high | $0.1997 |
| 52-week low | $0.1588 |
| Median price | $0.1832 |
| Average price | $0.1848 |
| Largest weekly change | +12.6% (Oct 22, 2025) |
| Weeks tracked | 73 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Succinate ER Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.1880 per EA (NDC 67877059305), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 11.4%. It has been tracked across 73 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since May 14, 2025, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1588 (Sep 17, 2025) to a high of $0.2122 (May 14, 2025), with a median of $0.1832 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 67877059305) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.